Cooperative modulation of gastrointestinal mucosal defence by prostaglandins and nitric oxide

Clinical and Investigative Medicine

Volumn 19, Issue 5, 1996, Pages 346-351

  Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

CONFERENCE PAPER; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INTESTINE INJURY; INTESTINE MUCOSA; LYMPHOCYTE; MAST CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; NITRIC OXIDE; PROSTAGLANDINS;

EID: 0029830408     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Wallace JL, McKnight GW, Keenan CM, Byles NIA, MacNaughton WK. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology 1990;98:1178-86.
2. Rioux KP, Wallace JL. Mast cell activation augments gastric mucosal injury through a leukotriene-dependent mechanism. Am J Physiol 1994;266:G863-9.
3. Franco-Brown S, Masson GMC, Corcoran AC. Induction of acute gastric lesions by histamine liberators in rats: effects thereon of pharmacologic blocking agents. J Allergy 1959;30:1-10.
4. Wallace JL, Cirino G, De Nucci G, McKnight GW, MacNaughton WK. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Am J Physiol 1989;256:G661-6.
5. Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di-Matteo FN, Morelli A. Pentoxifylline prevents indomethacin induced acute mucosal damage in rats: role of tumour necrosis factor alpha. Gut 1994;35:909-15.
6. Rosam A-C, Wallace JL, Whittle BJR. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature 1986;319:54-6.
7. 2, Biochem Biophys Res Commun 1986;137:404-10.
8. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988;263:5380-4.
9. Spatafora M, Chiappara G, D'Amico D, Volpes D, Melis M, Pace E, et al. Effect of indomethacin on the kinetics of tumour necrosis factor alpha release and tumour necrosis factor alpha gene expression by human blood monocyte. Pharmacol Res 1991;23:247-57.
10. Martich GD, Dannen RL, Ceska M, Saffredini AF. Detection of interleukin-8 and tumour necrosis factor in normal humans after intravenous endotoxin administration: the effect of anti-inflammatory agents. J Exp Med 1991;173:1021-4.
11. Appleyard CB, Tigley AW, Swain MG, Wallace JL. TNFa is a critical mediator of NSAID-induced gastric ulceration in rats [abstract]. Gastroenterology 1995; 108:A47.
12. Kunkel SL, Chensue SW. Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Commun 1985;128:892-7.
13. Kunkel SL, Chensue SW, Phan SH. Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 1986;136:186-92.
14. Raud J. Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation. Br J Pharmacol 1990;99:449-54.
15. Hogaboam CM, Bissonnette EY, Chin BC, Befus AD, Wallace JL. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993;104:122-29.
16. Robert A. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prost Thrombox Res 1976;2:507-20.
17. Wallace JL, Granger DN. Pathogenesis of NSAID gastropathy: Are neutrophils the culprits? Trends Pharmacol Sci 1992;13:129-31.
18. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Granulocytes: the culprit in ischemic damage to the intestine. Am J Physiol 1987;253:H699-703.
19. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci 1988;33:6S-15S.
20. Wallace JL, Higa A, McKnight GW, MacIntyre DE. Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence. Inflammation 1992;16:343-54.
21. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukocyte Biol 1994;55:662-75.
22. Asako H, Kubes P, Wallace JL, Gaginella T, Wolf RE, Granger DN. Indomethacin induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am J Physiol 1992;262:G903-8.
23. Asako H, Kubes P, Wallace JL, Wolf RE, Granger DN. Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology 1992;103:146-52.
24. Gryglewski RJ, Szczeklik A, Wandzilak M. The effect of six prostaglandins, prostacyclin and iloprost on generation of Superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formylmethionyl-leucyl-phenylalanine. Biochem Pharmacol 1987;36:4209-12.
25. 4 release from activated neutrophils. Proc Natl Acad Sci U S A 1983;80:4349-53.
26. Haurand M, Floh L. Leukotriene formation by human polymorphonuclear leukocytes from endogenous arachidonate. Physiological triggers and modulation by prostanoids. Biochem Pharmacol 1989;38:2129-37.
27. Kainoh M, Imai R, Umetsu T, Hattori M, Nishio S. Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes. Biochem Pharmacol 1990;39:477-84.
28. 2, dexamethasone, and IL-4. J Immunol 1993;151:2166-75.
29. Wong K, Freund F. Inhibition of n-formylmethionyleucyl-phenylalanine induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series. Can J Physiol Pharmacol 1981;59:915-20.
30. Wallace JL, McKnight W, Miyasaka M, Tamatani T, Paulson J, Anderson DC, et al. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol 1993;265:G993-8.
31. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991;88:4651-5.
32. Kubes P, Kanwar S, Niu X-F, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via Superoxide and mast cells. FASEB J 1993;7:1293-9.
33. Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994;266:G222-9.
34. Gaboury JP, Johnston B, Niu X-F, Kubes P. Mechanisms underlying acute mast cell-induced leukocyte rolling and adherence in vivo. J Immunol 1995; 154:804-13.
35. Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992;262:G1138-42.
36. Salvemini D, Masini E, Pistelli A, Mannaioni PF, Vane JR. Nitric oxide: a regulatory mediator of mast cell reactivity. J Cardiovasc Pharmacol 1991;17: S258-64.
37. Barrachina MD, Calatayud S, Moreno L, Pique JM, Whittle, BJR, Esplugues JV. Nitric oxide generation modulates the inhibition by interleukin-1β of pentagastrin-stimulated gastric acid secretion in the rat. Gut 1993;34:S11.
38. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 1993; 90:7240-4.
39. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 1995;114:1335-42.
40. MacNaughton WK, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989;45:1869-76.
41. Whittle BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990;99:607-11.
42. Kitagawa H, Takeda F, Kohei H. Effects of endothelium-derived relaxing factor on the gastric lesion induced by HC1 in rats. J Pharmacol Exp Ther 1990; 253:1133-7.
43. Wallace JL, Reuter BK, Cirino G. Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity. J Gastroenterol Hepatol 1994;9:S40-4.
44. Lopez-Belmonte J, Whittle BJR, Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993;108:73-8.
45. Boughton-Smith NK, Hutcheson IR, Deakin AM, Whittle BJR. Protective effect of S-nitroso-N-acetylpenicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 1990;191:485-8.
46. Tepperman BL, Soper BD. Nitric oxide synthase induction and cytoprotection of rat gastric mucosa from injury by ethanol. Can J Physiol Pharmacol 1994;72: 1308-12.
47. Beck PL, McKnight W, Lee SS, Wallace JL. Prostaglandin modulation of the gastric vasculature and mucosal integrity in cirrhotic rats. Am J Physiol 1993;265:G453-8.
48. 1 administration in cirrhotic rats. Gastroenterology 1993;105:1483-9.
49. Ferraz JGP, McKnight W, Sharkey KA, Wallace JL. Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis. Gastroenterology 1995;108:1183-91.
50. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G. Novel nonsteroidal antiinflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994;107:173-9.
51. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G. A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol 1994; 257:249-55.
52. Reuter BK, Cirino G, Wallace JL. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci 1994;55:PL1-8.